BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10344289)

  • 1. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
    Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
    Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
    Gupta M; Djalilvand A; Brat DJ
    Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
    Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
    Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
    Kunz J; Gottschalk J; Jänisch W; Schulz W
    Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
    Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
    No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uniform lineage of oligodendrogliomas.
    de la Monte SM
    Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GFAP in brain tumor diagnosis: possibilities and limitations.
    Gullotta F; Schindler F; Schmutzler R; Weeks-Seifert A
    Pathol Res Pract; 1985 Jul; 180(1):54-60. PubMed ID: 4034433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
    Hokama Y; Tanaka J; Nakamura H; Hori T
    No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
    Gottschalk J; Szymaś J
    Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
    Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
    J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
    Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN
    Am J Pathol; 2000 Sep; 157(3):1031-7. PubMed ID: 10980141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical study on Rosenthal fibers in gliomas using anti-GFAP and anti-ubiquitin antibodies].
    Kobayashi S; Mori H; Ikeuchi S; Takakura K
    No To Shinkei; 1990 Jan; 42(1):59-64. PubMed ID: 1692468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.
    Rettig WJ; Chesa PG; Beresford HR; Feickert HJ; Jennings MT; Cohen J; Oettgen HF; Old LJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6406-12. PubMed ID: 2877731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.